Breast Cancer :: Study aims to find which breast cancer patients need chemotherapy
Most postmenopausal women with small breast tumors don?t need chemotherapy to reduce their recurrence risk after lumpectomy.
Most postmenopausal women with small breast tumors don?t need chemotherapy to reduce their recurrence risk after lumpectomy.
In experiments with laboratory mice that bearaggressive human breast cancers, UC Davis researchers have used hotnanoprobes to slow the growth of tumors — without damage to surroundinghealthy tissue. The researchers describe their work in the March issue ofthe Journal of Nuclear Medicine.
High-temperature superconductors hold the key to a handheld tool for surgeons that promises to be more accurate, cost-effective and safer than existing methods for staging and treating various cancers, including breast cancer.
The American Society of Plastic Surgeons (ASPS) and the American Society for Aesthetic Plastic Surgery (ASAPS) have announced that fat grafting for breast augmentation is not recommended at this time based on the lack of safety and efficacy data, and amid concerns that the procedure may interfere with accurate detection of cancer.
Australian scientists believe they may be able to use a common cold-producingvirus to successfully treat breast cancer patients, in a way that is much lessdebilitating than chemotherapy.
Women who regularly engage in strenuous physical activity may have a lower risk of developing both invasive breast cancer and in situ (early-stage) breast cancer than women who do not, according to a report in the Feb. 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Significant findings have emerged from the California Teachers Study (CTS) that suggest long-term recreational physical activity plays a protective role against invasive and in situ breast cancer.
Industry-funded studies of breast cancer therapies are more likely to report positive results than non-pharmaceutical funded studies, researchers from the University of North Carolina at Chapel Hill and the Dana Farber Cancer Institute have found.
Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
African and African American women are more likely to die of breast cancer than their white counterparts because they tend to get the disease before the menopause, suggests new research from the University of East Anglia and the Children’s Hospital Boston in collaboration with researchers in the US and Italy.